Population pharmacokinetics of intravenous acetaminophen and its metabolites in major surgical patients
- 943 Downloads
Intravenous acetaminophen is a commonly used analgesic following surgery. The aims of this study were to determine the population pharmacokinetic profile of intravenous acetaminophen and its metabolites in adult surgical patients and to identify patient characteristics associated with acetaminophen metabolism in the postoperative period. 53 patients were included in the dataset; 28 were men, median age (range) 60 years (33–87), median weight (range) 74 kg (54–129). Patients received 1, 1.5 or 2 g of intravenous acetaminophen every 4–6 h. Plasma and urine samples were collected at various intervals for up to 6 days after surgery. Simultaneous modelling of parent acetaminophen and its metabolites was conducted in Phoenix® NLME™ to estimate pharmacokinetic parameters. The population mean estimate (CV%) for central (plasma) volume of distribution of parent acetaminophen (VC) was 13.9 (4.41) L, peripheral (tissue) volume of distribution (VT) was 50.9 (2.96) L, and intercompartmental clearance (Q) was 77.5 (9.29) L/h. The population mean (CV%) metabolic clearances for glucuronidation (CLPG) was 8.92 (3.25) L/h, sulfation (CLPS) was 0.903 (3.47) L/h, and oxidation (CLPO) was 0.533 (7.90) L/h. The population mean (CV%) urinary clearances of parent acetaminophen (CLRP) was 0.137 (5.46) L/h, acetaminophen glucuronide (CLRG) was 3.81 (6.71) L/h, acetaminophen sulfate (CLRS) was 3.13 (4.32) L/h, and acetaminophen cysteine + mercapturate (CLRO) was 3.51 (9.98) L/h. Age was found to be a significant covariate on the formation of acetaminophen glucuronide, and renal function (estimated as creatinine clearance) on the urinary excretion of acetaminophen glucuronide.
KeywordsAcetaminophen Analgesia Surgery Population pharmacokinetics Drug metabolism Phoenix NLME
The authors would like to thank the School of Pharmacy, University of Otago for Katie Owens’ PhD Scholarship and Pharsight (Mountain View, CA, USA) for the provision of Phoenix® NLME™.
- 2.Murphy PGM (2012) Paracetamol metabolism in postoperative patients. National University of Ireland, Cork, IrelandGoogle Scholar
- 3.Perfalgan Medicine Data Sheet: Medsafe Data Sheet: Perfalgan [Online] (2012) http://www.medsafe.govt.nz/profs/datasheet/p/Perfalganinf.pdf. Accessed 05 Apr 2012
- 16.Leary R, Dunlavey M (eds) (2012) QRPEM, a quasi-random parametric EM method. PAGE, VeniceGoogle Scholar
- 17.Leary R, Dunlavey M, Chittenden J, Matzuka B, Guzy S (2012) QRPEM—a new standard of accuracy, precision, and efficiency in NLME population PK/PD methods. Pharsight® A Certara™ Company © 2011 Tripos, L.P. All Rights ReservedGoogle Scholar
- 23.Prescott L (1996) Paracetamol (acetaminophen): a critical bibliographic review. Taylor & Francis Ltd, LondonGoogle Scholar
- 26.Fouad EA, Ali MS, Kotb HMI, Emara S, Fracs MS, El Minshawy A (2009) Effect of cardiopulmonary bypass on the pharmacokinetics of intravenous paracetamol. Saudi Pharm J 17(2):130–136Google Scholar